SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001193125-24-103050
Filing Date
2024-04-19
Accepted
2024-04-19 17:14:36
Documents
5

Document Format Files

Seq Description Document Type Size
1 S-1 d827405ds1.htm S-1 431591
2 EX-10.18 d827405dex1018.htm EX-10.18 103662
3 EX-23.1 d827405dex231.htm EX-23.1 1971
4 EX-FILING FEES d827405dexfilingfees.htm EX-FILING FEES 33795
5 GRAPHIC g827405g02a02.jpg GRAPHIC 36963
  Complete submission text file 0001193125-24-103050.txt   623045
Mailing Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339
Business Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339 678-392-3419
Inhibikase Therapeutics, Inc. (Filer) CIK: 0001750149 (see all company filings)

IRS No.: 263407249 | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-278844 | Film No.: 24858878
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)